Keyphrases
Central Nervous System
100%
Monocytes
100%
AS101
100%
T Cell Infiltration
100%
Experimental Autoimmune Encephalomyelitis
100%
Tellurium Compounds
100%
VLA-4
62%
T Cells
37%
Integrin
37%
CD49d
25%
Leukocytes
25%
Infiltration
25%
Macrophages
25%
Inflammatory Cytokines
25%
Disease Process
25%
Multiple Sclerosis
25%
Cytokine Levels
25%
Multiple Sclerosis Treatment
25%
CD4+
12%
Apoptosis
12%
Inflammatory Response
12%
Autoreactive T Cells
12%
Blood-brain Barrier
12%
Mouse Model
12%
Monkey
12%
Nervous System Diseases
12%
Healthy Donors
12%
Monocyte-derived Macrophages
12%
Macrophage Cells
12%
Inflammatory Autoimmune Disease
12%
Ammonium
12%
Tellurate
12%
Inflammatory Diseases
12%
Behavioral Deficits
12%
Spinal Cord
12%
Myelin
12%
Therapeutic Efficacy
12%
Tellurium(IV)
12%
Neurodegenerative Processes
12%
Multiple Sclerosis Model
12%
Anti-inflammatory Cytokines
12%
Alpha Subunit
12%
CD49
12%
Inflammatory Monocytes
12%
Demyelinating Process
12%
Peripheral Populations
12%
CD11b+
12%
Immunology and Microbiology
Monocyte
100%
Central Nervous System
100%
Cell Infiltration
100%
Experimental Autoimmune Encephalomyelitis
100%
T Cell
100%
Multiple Sclerosis
66%
Experimental Allergic Encephalitis
66%
Macrophage
50%
Integrin
50%
Inflammatory Cytokine
33%
CD49d
33%
Leukocyte
33%
Monospecific Antibody
16%
Inflammatory Disorder
16%
Treatment of Multiple Sclerosis
16%
Inflammation Response
16%
Autoimmune Disease
16%
CD4
16%
Mouse Model
16%
Mouse
16%
Proinflammatory Cytokine
16%
Blood Brain Barrier
16%
Spinal Cord
16%
Haplorhini
16%
Myelin
16%
Alpha Chain
16%
Pharmacology, Toxicology and Pharmaceutical Science
Tellurium Derivative
100%
Ammonium Trichloro(dioxyethylene O,o')tellurate
100%
Experimental Autoimmune Encephalomyelitis
100%
Multiple Sclerosis
62%
Experimental Allergic Encephalitis
50%
Integrin
37%
Cytokine
37%
Disease
25%
Mouse
12%
Blood-Brain Barrier
12%
Mouse Model
12%
Anti-Inflammatory Drug
12%
Haplorhini
12%
Inflammatory Disease
12%
Autoimmune Disease
12%
Inflammation
12%
Combination Therapy
12%
Myelin
12%